Patents by Inventor Richard H. Malavarca

Richard H. Malavarca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4828987
    Abstract: Recombinant DNA molecules in which an avian retroviral long terminal repeat (LTR) has been ligated to the bovine growth hormone gene are described herein. The retroviral LTR was derived from a plasmid clone of a Schmidt Rupin strain of Rous Sarcoma Virus while the bovine growth hormone (BGH) gene was derived from a lambda-bacteriophage genomic library. Using a transient eucaryotic expression assay system, the plasmid constructs were screened for their ability to direct expression and secretion of bovine growth hormone. These constructs were co-transformed into a mammalian cell (mouse) culture in order to obtain a stable cell culture secreting large amounts of bovine growth hormone.
    Type: Grant
    Filed: May 14, 1984
    Date of Patent: May 9, 1989
    Assignee: Merck & Co., Inc.
    Inventors: John J. Kopchick, Frederick C. Leung, Thomas J. Livelli, Richard H. Malavarca
  • Patent number: 4686098
    Abstract: Recombinant DNA constructs having an avian retroviral long terminal repeat (LTR) ligated to the bovine growth hormone gene, were co-transformed into a mammalian cell (mouse) culture in order to obtain a stable cell culture secreting large amounts of bovine growth hormone. The transformed mouse cells were encapsulated in hollow fibers and implanted into animals, thereby producing circulating bovine growth hormone.
    Type: Grant
    Filed: May 14, 1984
    Date of Patent: August 11, 1987
    Assignee: Merck & Co., Inc.
    Inventors: John J. Kopchick, Frederick C. Leung, Thomas J. Livelli, Richard H. Malavarca